{"public_id":"cl_61647a485f0b10e05a6421eea7de99e3","status":"active","superseded_by_public_id":null,"corpus_id":28659266,"text":"Type 2 diabetes mellitus is associated with a 3-fold increased risk of hepatocellular carcinoma, with prevalence significantly higher in HCC patients than in matched controls (31.2% vs 12.7%; OR = 3.12, 95% CI: 2.22-4.43).","confidence":0.92,"paper":{"corpus_id":28659266,"title":"Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.","url":"https://sah.borca.ai/papers/28659266"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.92,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_729c21c9447884129ecc8569fc941732","name":"type 2 diabetes mellitus","description":"A metabolic disease characterized by insulin resistance and hyperglycemia, examined here as a potential risk factor for hepatocellular carcinoma.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_729c21c9447884129ecc8569fc941732"},{"public_id":"co_9be49a36f966e93b4b2cd26030a21a4c","name":"hepatocellular carcinoma","description":"A primary liver cancer that is the disease outcome studied in relation to diabetes status in this case-control study.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_9be49a36f966e93b4b2cd26030a21a4c"},{"public_id":"co_e883c640eab6acbd3f9c9172067a6815","name":"odds ratio","description":"A statistical measure of association used here to quantify the relative risk of hepatocellular carcinoma associated with type 2 diabetes mellitus.","types":["statistical measure"],"url":"https://sah.borca.ai/concepts/co_e883c640eab6acbd3f9c9172067a6815"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_61647a485f0b10e05a6421eea7de99e3"}